GCIS
GlobalChemical Inventory Search
Zolmitriptan
(S)-4-[3-[2-(二甲胺基)乙基]-1H-吲哚-5-甲基]-2-噁唑烷酮
,
氘代佐米曲普坦-d6
,
佐米曲坦
,
(S)-4-[[3-[2-(二甲氨基)乙基]-1H-吲哚-5-基]甲基]-2-恶唑烷酮, 2-Oxazolidinone, 4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-, (4S)-, BW 311C90, (S)-4-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone, Zomigoro, (4S)-4-({3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one, Zolmitriptan, Zomigon, (4R)-4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one, (S)-N,N-Dimethyl-2-[5-(2-oxo-1,3-oxazolidin-4-ylmethyl)-1H-indol-3-yl]ethylamine, AscoTop, Zomig, MFCD00871503
CAS Number: 139264-17-8
IUPAC name: (4S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one
Molecular formula: C16H21N3O2
Molecular weight: 287.357
InChI: InChI=1S/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)/t13-/m0/s1
InChIKey: ULSDMUVEXKOYBU-ZDUSSCGKSA-N
SMILES: -
EINECS: CN(C)CCC1=CNC2=C1C=C(C=C2)C[C@H]3COC(=O)N3
One-Click Alert
Download ReportRegions
Filter All
Inventory Categories
Filter All
Sort
By key inventories
By listed
Focused on chemical complianceEmpowering the entire lifecycle of the chemical industry
Substance Information
CAS Number:
139264-17-8
Chemical Name:
Zolmitriptan
Chinese name:
佐米曲普坦
Date of inquiry :
Apr 5, 2026
Inquiry website:
https://www.chemradar.com/en/tools/gcisGCIS inquiry report
| Inventory Name | Country/Region | Status | Obligations |
|---|
ChemRadar
Global chemical compliance information, data and technical service platform
Service Hotline: +353 1 477 3710 (EU) +86 571 8720 6598 (CN) +81 70 9365 8022 (JP) +82 2 6347 8816 (KR)
Disclaimer
1.
CIRS aims to keep the content of this site accurate and up to date. However, CIRS makes no warranties or representations regarding the quality, accuracy, completeness or reliability of information on the site.
2.
In no event shall CIRS assume or have any responsibility or liability for any information on this site or for any claims, damages or losses resulting from their use.
3.
CIRS reserves the right, at our discretion, to change, modify, add to, or remove portions of information on this site at any time without notice.
